SLEEVE GASTRECTOMY TO CORRECT OBESITY AND ASSOCIATED CO-MORBIDITIES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Obesity has become a serious health problem and it is a major risk factor for the development of insulin resistance and type 2 diabetes mellitus (T2DM). Laparoscopic sleeve gastrectomy (LSG) has revealed to be effective for achieving weight loss and a potential competitor with other operations. The aim of this study is to evaluate weight loss and the reversibility of associated comorbidities in obese T2DM patients, one and three months after LSG. Data collected between January 1st – June 30th 2011 from 23 subjects with obesity and T2DM were analyzed retrospectively. The following parameters recorded before, one and three months after surgery were compared: body mass index (BMI), fasting plasma glucose, lipid profile, arterial blood pressure, hypoglycemic drugs, antihypertensive and hypolipidemic drugs. Mean BMI decreased from 45.17 ± 8.342kg/m² to 39 ± 6.031kg/m² at one month and to 34.91 ± 4.435kg/m² 3 months after surgery. Fasting plasma glucose decreased to 117.87 ± 35.143mg/dl at one month and to 102.22 ± 16.605mg/dl, 3 months after surgery. Following surgery, a full remission of T2DM was achieved in 39% of patients in the first month and in 65% of patients at 3 months. There was also an important improved in lipid profile, blood pressure control and obstructive sleep apnea (OSA). Our study has shown positive early effects of LSG on obese T2DM patients regarding weight loss and obesity - related comorbidities reduction.
Authors and Affiliations
Mihaela Lavinia Moanta, Ilie-Robert Dinu, Maria Mota, C Copăescu
Keywords
Related Articles
- EP ID EP150540
- DOI -
- Views 127
- Downloads 0
FEEDING, BIRTH WEIGHT AND RANK INFLUENCE ON THE RISK OF DIABETES MELLITUS IN CHILDREN
Background: The etiology of type 1 diabetes mellitus supposes the existence of genetic factors, but also environmental ones, of nutritional, fetal (e.g. birth weight) perinatal nature. This study aims at identifying food...
HEPATIC FIBROSIS, MEASURED BY FIBROSCANIN A GROUP OF PATIENTS WITH OBESITY
Introduction. Hepatic steatosis is a reversible condition caused by accumulation of triglycerides in liver cells. Non-alcoholic fatty liver disease (NAFLD) can progress to advanced liver disease: fibrosis, cirrhosi...
NOCTURNAL HYPERTENSION AND SPECIAL - PERIOD HYPERTENSION IN TYPE 1 DIABETES MELLITUS
Background: One of the unique aspects of continuous ambulatory arterial-tension monitoring is the ability of recording the diurnal variations. The patients suffering from Type 1 Diabetes Mellitus (T1DM) may present...
METABOLIC SYNDROME – THE "SILENT KILLER", A CONTINUING CHALLENGE
Metabolic syndrome, also known as dysmetabolic/plurimetabolic syndrome, X syndrome, insulinresistance syndrome or deadly quartet is an aggregate of interrelated metabolic abnormalities that occur with a higher prevalence...
THE RELATIONSHIP BETWEEN 1 HOUR GLYCEMIA, DURING ORAL GLUCOSE TOLERANCE TEST AND CARDIOMETABOLIC RISK
Background Diabetes mellitus is a very common disease, worldwide there are currently over 366 million diabetics. It seems that people with normal glucose tolerance and blood glucose at 1 hour during OGTT ≥200mg% re...